In vitro activity of tomopenem (CS-023/RO4908463) against anaerobic bacteria

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 1, 2009, Pages 319-322

  Tanaka, Kaori ^a   Mikamo, Hiroshige ^b   Nakao, Kenichi ^a   Ichiishi, Taku ^a   Goto, Takatsugu ^a   Yamagishi, Yuka ^b   Watanabe, Kunitomo ^a  

^a GIFU UNIVERSITY   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; DORIPENEM; MEROPENEM; METRONIDAZOLE; PANIPENEM; TOMOPENEM;

AGAR DILUTION; ANAEROBIC BACTERIUM; ANAEROBIC INFECTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; DRUG POTENCY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; CARBAPENEMS; MICROBIAL SENSITIVITY TESTS; THIENAMYCINS;

EID: 59749084502     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00595-08     Document Type: Article

References (15)

1. Aldridge. K. E. 2002. Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes. Diagn. Microbiol. Infect. Dis. 44:181-186.
2. Goldstein, E. J. C., D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, and H. Fernandez. 2002. Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections. Antimicrob. Agents Chemother. 46:1136-1140.
3. Holdeman, L. V., and W. E. C. Moore. 1977. Anaerobic laboratory manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg, VA.
4. Jousimies-Somer, H. R., P. Summanen, D. M. Citron, E. J. Baron, H. M. Wexler, and S. M. Finegold. 2002. Wadsworth-KTL anaerobic bacteriology manual, 6th ed. Star Publishing Co., Belmont, CA.
5. Kawamoto, I., Y. Shimojo, O. Kanno, K. Kojima, K. Ishikawa, E. Matsuyama, Y. Ashida, T. Shibayama, T. Fukuoka, and S. Ohya. 2003. Synthesis and structure-activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety. J. Antibiot. (Tokyo) 56:565-579.
6. Koga, T., T. Abe, H. Inoue, T. Takenouchi, A. Kitayama, T. Yoshida, N. Masuda, C. Sugihara, M. Kakuta, M. Nakagawa, T. Shibayama, Y. Matsushita, T. Hirota, S. Ohya, Y. Utsui, T. Fukuoka, and S. Kuwahara. 2005. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem. Antimicrob. Agents Chemother. 49:3239-3250.
7. Livermore, D. M., M. W. Carter, S. Bagel, B. Wiedemann, F. Baquero, E. Loza, H. P. Endtz, N.van den Braak, C. J. Fernandes, L. Fernandes, N. Frimondt-Moller, L. S. Rasmussen, H. Giamarellou, E. Giamarellous-Bourboulis, V. Jarlier, J. Nguyen, C-E. Nord, M. J. Struelens, C. Nonhoff, J. Turnidge, J. Bell, R. Zbinden, S. Pfister, L. Mixson, and D. L. Shungu. 2001. In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob. Agents Chemother. 45:1860-1867.
8. National Committee for Clinical Laboratory Standards. 2004. Methods for antimicrobial testing of anaerobic bacteria, 6th ed. Approved standard. NCCLS M11-A6. National Committee for Clinical Laboratory Standards, Wayne, PA.
9. Shibayama, T., Y. Matsushita, T. Hirota, T. Ikeda, and S. Kuwahara. 2006. Pharmacokinetics of CS-023 (RO4908463), a novel parenteral carbapenem, in healthy male Caucasian volunteers. Antimicrob. Agents Chemother. 50:4186-4188.
10. Shibayama, T., D. Sugiyama, E. Kamiyama, T. Tokui, T. Hirota, and T. Ikeda. 2007. Characterization of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, and meropenem as substrates of human renal transporters. Drug Metab. Pharmacokinet. 22:41-47.
11. Shibayama, T., Y. Matsushita, K. Kawai, T. Hirota, T. Ikeda, and S. Kuwahara. 2007. Pharmacokinetics and disposition of CS-023 (RO4908463), a novel parenteral carbapenem, in animals. Antimicrob. Agents Chemother. 51:257-263.
12. Summanen, P., E. J. Baron, D. M. Citron, C. A. Strong, H. M. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing Co., Belmont, CA.
13. Sundelof, J. G., R. Hajdu, C. J. Gill, R. Thompson, H. Rosen, and H. Kropp. 1997. Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primates. Antimicrob. Agents Chemother. 41:1743-1748.
14. Thomson, K. S., and E. S. Moland. 2004. CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa. J. Antimicrob. Chemother. 54:557-562.
15. Wexler, H. M. 2004. In vitro activity of ertapenem: review of recent studies. J. Antimicrob. Chemother. 53(Suppl. 2):ii11-ii21.